🏢 公司NewsroomTNDMCodex · 实盘不做把握 9/10
北京时间·🕒 发布 04:05:23·⟳ 抓取 04:10:14 +4m51s·⚡ 决策 07-29 04:10:41 +27s·90.7 天前
Tandem Diabetes Care宣布将参加Canaccord增长会议并做公司更新
这只是公司例行投资者会议/网络直播安排，没有披露订单、产品审批、业绩指引或可量化经营增量。
📄 原文TNDM↗ 原文
Tandem Diabetes Care Announces Upcoming Conference Presentation
Content Import Tue, 07/28/2026 - 16:05 Tandem Diabetes Care Announces Upcoming Conference Presentation Jul 28, 2026 Gen…
不做 Tandem Diabetes Care（TNDM.US）
例行投资者会议排期公告，没有新增经营、订单、审批或指引信息，无法形成正期望交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-28 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是公司例行投资者会议/网络直播安排，没有披露订单、产品审批、业绩指引或可量化经营增量。
主要风险
- 若8月11日会议现场披露超预期经营信息，需要由新信号重新研判。
原文全文
展开原文 · 2,159 字
Tandem Diabetes Care Announces Upcoming Conference Presentation
Content Import
Tue, 07/28/2026 - 16:05
Tandem Diabetes Care Announces Upcoming Conference Presentation
Jul 28, 2026
General
SAN DIEGO--(BUSINESS WIRE)--Jul. 28, 2026--
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuity’s 46 th Annual Growth Conference on Tuesday, August 11, 2026 at 1:30pm Eastern Time (10:30am Pacific Time).
The presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
Tandem Diabetes Care, the Tandem logo, Control-IQ+, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260728873750/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
SAN DIEGO --(BUSINESS WIRE)--Jul. 28, 2026-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuity’s 46 th Annual Growth Conference on Tuesday, August 11, 2026 at
Content Import
Tue, 07/28/2026 - 16:05
Tandem Diabetes Care Announces Upcoming Conference Presentation
Jul 28, 2026
General
SAN DIEGO--(BUSINESS WIRE)--Jul. 28, 2026--
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuity’s 46 th Annual Growth Conference on Tuesday, August 11, 2026 at 1:30pm Eastern Time (10:30am Pacific Time).
The presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
Tandem Diabetes Care, the Tandem logo, Control-IQ+, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260728873750/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
SAN DIEGO --(BUSINESS WIRE)--Jul. 28, 2026-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuity’s 46 th Annual Growth Conference on Tuesday, August 11, 2026 at
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。